|ETF Long Name||iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)|
|ETF Short Name||ISHARES IV PLC ISHARES NASDAQ U|
|ETF Issuer/Fund House/AMC||Ishares IV PLC|
|Primary Category/Asset Class||Biotechnology|
|Country of ETF Incorporation||Ireland|
|MiFIR Identifier Code||ETFS|
|LSE Market Code||MAIN MARKET|
|FCA Listing Category||Premium Equity Open Ended Investment Companies|
|Market Segment Code||EUE2|
|Market Sector Code||UE2I|
|Other Categories||, NASDAQ, Index-based, UCITS, Biotechnology, Healthcare,|
|Expense Ratio:||Not Available|
@Lonli-Lokli Have you checked out iShares Healthcare Innovation UCITS ETF (HEAL) which is already available on FT? A number of the companies may be the same in each ETF.
I believe you mean DRDR?
No, I haven’t, will take a look
@Lonli-Lokli Yes, DRDR. It comes up as HEAL on the iShares website.
DRDR is 5x bigger, 0.4 vs 0.35 fee and is 65% on US vs 90% for BTEK.
As for me this ETFs are different
FT actually had BTEK on the platform about a year ago however they had a technical issue with the ETF which meant that they had to remove it as no trades were going through. They haven’t added it back on so I hope they can find the time to sort this out
Its in the app now!
I just don’t get why it’s listed in app with £0.05 while Google says it’s £5